Breaking News on Global Pharmaceutical Technology & Manufacturing

Mergers and acquisitions

The pharmaceutical industry seems besieged on all sides, with declining R&D productivity, expiring patents on blockbuster products and relentless downward pricing pressure forcing companies to look closely at the bottom line. One affect of this onslaught has been an upsurge in the level of M&A activity as players within the industry consolidate to cut costs, expand research pipelines and lengthen geographic reach.

Teva Doubles Production as Japanese Change Attitude to Generics

09-Jul-2013 - Teva says it will reap the benefits of changing attitudes to generic drugs in Japan as it doubles its production capacity in the country.

MicroDose of Fresh Air for Teva with Respiratory Acquisition

18-Jun-2013 - Teva has affirmed its respiratory drug delivery strategy with the purchase of MicroDose Therapeutx for a potential $165m (€123m).

News in brief

Sun Pharma Looking to Grow but Meda Denies Takeover Discussions

05-Jun-2013 - Swedish allergy drug company Meda has denied it has been in discussions with Sun Pharma over a possible $5bn (€3.8bn) takeover.

GSK's €250m Acquisition Brings T-Cell Vaccine Tech In-House

30-May-2013 - GlaxoSmithKline has brought its vaccine development in-house with the purchase of Okairos and its supplementary technology platform.

BMS to Shutter Ex-Amylin Facility - Redundancies Inevitable

09-Apr-2013 - Bristol-Myers Squibb says shuttering Amylin’s San Diego facilities will accelerate its diabetes R&D joint venture with AstraZeneca though approximately 300 jobs will be lost.

AmerisourceBergen Exits Contract Packaging and Canadian Distribution

03-Apr-2013 - AmerisourceBergen has sold AndersonBrecon for $308m, exiting the contract packaging business in order to concentrate on its core business.

Shire's Vision Strengthened with $160m Acquisition

26-Mar-2013 - Shire says it is laying down a foundation into the specialty ophthalmology field following its second acquisition in a matter of weeks.

AB Technology Buys Angel's Edinburgh Assets

19-Mar-2013 - As the dissolution of Angel continues, its core manufacturing facility has been bought by AB Technology ensuring long term operations and rescuing 23 jobs.

Fallen Angel Sells Collagen Supply Wing to Collbio

18-Mar-2013 - Following last week’s shuttering of a manufacturing plant administrators have sold Angel Biomedical to new company Collbio as they start offloading CMOs assets.

Shire Snaps Up Swedish Infant Blindness Drug Developer

14-Mar-2013 - Shire has entered the neonatology market by acquiring Premacure and a new therapy and delivery technology designed to treat infant blindness.

Actavis Shutters Unit Following Watson Takeover R&D Double-Up

14-Mar-2013 - Following an analysis of its global R&D business Actavis says it will close its Maltese R&D unit at a cost of 60 jobs.

Patheon to Shutter Manufacturing Plant as Part of Banner Integration

12-Mar-2013 - Patheon says the shuttering of one of Banner’s manufacturing sites is necessary in integrating the recent acquisition into its global business structure.

Mylan Buys Agila Citing Global Injectable Drug Shortages as Driver

04-Mar-2013 - Mylan says its acquisition of Agila puts the generics company in a “leading position” in the injectables market.

Capsugel Buys Encap as Part of Dosage Form Solution Strategy

01-Mar-2013 - Capsugel says the acquisition of Encap is part of its recently announced Dosage Form Solutions (DFS) strategy.

Oral Dose Competition Intensifies as Qualicaps Expands Manufacturing

26-Feb-2013 - Following a bout of investments, the oral dose solution market has been described as “competitive” and “dynamic” by two of the major players.

IMCD Buys Indian Distributor Indchem for Pharma business

20-Feb-2013 - Chemical distributor IMCD Group says acquisition of Mumbai-based Indchem will build its presence in the Indian pharmaceutical excipient sector.

Unichem Sell Indian Formulation Plant to Mylan

19-Feb-2013 - Mylan Laboratories has purchased a new finished formulations facility in an Indian Special Economic Zone from Unichem Laboratories.

Merck: ‘In-House API Production Remains Important Strategy’

14-Feb-2013 - Merck says it will keep in-house API production capacity as it continues to evaluate its manufacturing strategy.

Update

Teva to Sell Californian Plant as Part of Cost-Cutting Initiative

11-Feb-2013 - Teva says the offloading of its Californian manufacturing facility is part of cost-cutting plans designed to save $2bn (€1.5bn). in the next few years.

News in brief

Sun Takeover Bid Burns Out as Taro Grows

11-Feb-2013 - Sun Pharmaceutical Industries has abandoned its long running efforts to buy Israel’s Taro, explaining the move is in the best interest of shareholders.

breaking news - update

BASF sees synergies between new acquisition Pronova and Equateq

21-Jan-2013 - BASF has had its offer for omega-3 API maker Pronova Biopharma accepted by 97.7 per cent of the Norwiegan firm’s shareholders.

Exclusive - update

Odin likely to accept revised offer for Pronova says BASF

18-Jan-2013 - German chemicals giant BASF expects its revised takeover bid for Norwegian omega-3 API manufacturer Pronova Biopharma ASA to be accepted by resistant shareholders.

update

Greece is the word: BASF tells Pronova shareholders revised bid is fair value

15-Jan-2013 - BASF says revised offer for omega-3 API maker Pronova Biopharma is fair value given recent Greek Government decision to stop reimbursing two key drugs. 

Symrise-Probi partnership to deliver probiotic goods in 2014-15

20-Dec-2012 - German fragrance and flavours house Symrise has just last night inked a deal with Swedish probiotics firm Probi to develop a stand-alone R&D project with oral probiotic supplements the most...

Key Industry Events

 

Access all events listing

Our events, Events from partners...